Buy Sagility India; target of Rs 55: ICICI Securities

Moneycontrol • 9 days ago

Original source

Key Investment Pillars

  • Efficient margin execution: Sagility reported a record high EBITDA margin of 26.1% despite wage hikes, driven by its ability to maintain cost discipline and improve operational efficiency.
  • Robust pipeline: The company's pipeline is strong, with a record high TCV of USD 40.2mn, up 18% YoY, indicating a healthy demand for its services.
  • Focus on provider business: Sagility is increasing its efforts in the provider segment, aiming to grow this business at a higher pace, and has acquired Chirok Health to strengthen its presence in this segment.
  • Chirok acquisition: The acquisition of Chirok Health is expected to help Sagility revive growth in the provider segment, which has been slowing down, and provides access to a broader base of mid-small segment clients.

Thesis Validation Checklist

  • Revenue growth: Investors should watch for Sagility's ability to maintain its revenue growth guidance of low double-digit organic growth for FY27.
  • Margin expansion: The company's ability to expand its EBITDA margin, currently at 26.1%, will be crucial in validating the investment thesis.
  • Pipeline growth: A continued strong pipeline, with TCV growth, will be essential in supporting the investment thesis.
  • Integration of Chirok Health: The successful integration of Chirok Health and its contribution to Sagility's provider segment growth will be important in validating the thesis.
  • Industry trends: The US healthcare industry's trends, including the demand for services and the impact of policy changes, will also be crucial in validating the investment thesis.